ID UKF-NB-2rDOX20 AC CVCL_RS01 DR Wikidata; Q54990295 RX PubMed=22170099; RX PubMed=24466371; WW Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php CC Part of: Resistant Cancer Cell Line (RCCL) collection. CC Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin). CC Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. DI NCIt; C3270; Neuroblastoma DI ORDO; Orphanet_635; Neuroblastoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_9902 ! UKF-NB-2 CA Cancer cell line DT Created: 05-03-18; Last updated: 10-04-25; Version: 8 // RX PubMed=22170099; DOI=10.1038/cddis.2011.129; PMCID=PMC3252738; RA Michaelis M., Rothweiler F., Barth S., Cinatl J., van Rikxoort M., RA Loschmann N., Voges Y., Breitling R., von Deimling A., Rodel F., RA Weber K., Fehse B., Mack E., Stiewe T., Doerr H.-W., Speidel D., RA Cinatl J. Jr.; RT "Adaptation of cancer cells from different entities to the MDM2 RT inhibitor nutlin-3 results in the emergence of p53-mutated RT multi-drug-resistant cancer cells."; RL Cell Death Dis. 2:e243.1-e243.8(2011). // RX PubMed=24466371; DOI=10.1593/tlo.13544; PMCID=PMC3890703; RA Loschmann N., Michaelis M., Rothweiler F., Zehner R., Cinatl J., RA Voges Y., Sharifi M., Riecken K., Meyer J., von Deimling A., RA Fichtner I., Ghafourian T., Westermann F., Cinatl J. Jr.; RT "Testing of SNS-032 in a panel of human neuroblastoma cell lines with RT acquired resistance to a broad range of drugs."; RL Transl. Oncol. 6:685-696(2013). //